About SEVEN

Built by a clinician.
Built for patients.

SEVEN exists because the gap between evidence-based metabolic care and what most people can actually access is too wide. We are building a platform to close it — starting with GLP-1 and expanding into the full spectrum of clinician-guided metabolic health.


Why SEVEN exists.

The modern food environment is not designed for metabolic health. Ultra-processed foods, engineered reward loops, and constant availability have fundamentally changed the way the human body responds to hunger — and traditional approaches to weight management have not kept pace.

Food noise — the persistent, intrusive mental preoccupation with eating — affects millions of people and is driven by neurobiology, not character. Appetite dysregulation is a physiological phenomenon. Metabolic adaptation is a clinical reality. Yet most weight loss programs still treat these as problems of motivation or discipline.

SEVEN was built on a different premise: that sustainable transformation requires clinical care, not willpower-based programs. GLP-1 medications are where we begin — but metabolic health encompasses far more. Hormonal balance, peptide therapy, and longevity medicine are all part of a complete picture that most telehealth platforms fail to address in an integrated, clinician-guided way.

That is what SEVEN is designed to be.


Clinician-guided.
Evidence-based. Long-term.

SEVEN's approach is grounded in three commitments that shape every aspect of how the platform is built and how care is delivered.

Individualized treatment

No two patients have the same metabolic history, health context, or treatment goals. Every SEVEN protocol is reviewed by a licensed clinician based on your individual intake — not a generic algorithm applied uniformly.

Evidence-based care

Treatment decisions at SEVEN are grounded in current clinical evidence. GLP-1 medications are among the most studied interventions in metabolic medicine, and SEVEN's protocols reflect what the evidence actually supports — including its limitations.

Long-term focus

SEVEN is not a quick-fix platform. Metabolic health is a long-term clinical endeavor. Programs are designed with sustainable outcomes in mind — not 30-day transformations that are difficult to maintain.

Ongoing support

Clinical support is not a feature at SEVEN — it is the foundation. Provider access, monitoring, and protocol adjustment are built into every program because treatment without oversight is not a complete clinical service.


What sets SEVEN apart.

Clinician-founded

SEVEN was built by a practicing clinician, not a venture-backed startup team. That origin shapes every decision — from how programs are structured to how clinical oversight is built into the platform.

Patient-first by design

Every aspect of SEVEN is built around the patient experience — transparent pricing, accessible care, and provider relationships that extend beyond a single prescription.

No shortcuts

SEVEN does not optimize for volume. Programs are reviewed individually, eligibility is determined clinically, and treatment is managed with the same standard of care applied in a traditional clinical setting.

Built for the long term

Metabolic health is not a 30-day problem. SEVEN is designed to support patients across the full arc of their health journey — from initial treatment through optimization and maintenance.


The future of SEVEN.

GLP-1 medical weight loss is where SEVEN begins. It is not where SEVEN ends.

Hormone therapy

Testosterone replacement therapy, hormone replacement therapy, and thyroid optimization are natural extensions of SEVEN's metabolic health model — individualized, clinician-prescribed, and built around long-term outcomes rather than quick fixes.

Peptide protocols

Sermorelin, NAD+, and other evidence-adjacent peptide therapies represent a growing area of clinician-guided wellness. SEVEN is building the clinical infrastructure to offer these responsibly — with appropriate oversight and patient selection.

Longevity & optimization

The intersection of metabolic health, hormonal balance, and longevity medicine is where SEVEN is headed. A platform that addresses the full spectrum of clinician-guided health — not just one condition, not just one medication class.


Clinician-written resources.

Understanding the science behind metabolic health is part of what we do. These articles are written for patients who want honest, evidence-grounded information.

Early Access

Join SEVEN early access.

Initial onboarding will be limited. Secure your place and receive your free GLP-1 Starter Guide.

Join Early Access →
Content on this website is reviewed by licensed healthcare professionals affiliated with SEVEN.